Heading to better Process control and Performances

Size: px

Start display at page:

Download "Heading to better Process control and Performances"

Grace Weaver
5 years ago
Views:

He joined Ceva in 1998 and since there he has held various positions. Today, Dr Sylvain is the Poultry Corporate Marketing Director - Executive Director.

1 Dr Sylvain Comte Dr. Comte graduated as veterinarian in 1993 be The National of Veterinary School of Nantes (France). Master of Sciences in Physiology and Agronomy be Rennes University (France). He started his professional carrier in Veterinary Services for Rural Development. He joined Ceva in 1998 and since there he has held various positions. Today, Dr Sylvain is the Poultry Corporate Marketing Director - Executive Director. He is in charge of Global Strategy and Business development for Vaccines and Pharmaceuticals for Poultry Innovation in Vaccination Hatchery Practices: Heading to better Process control and Performances Dr Sylvain Comte Poultry Corporate Marketing Director Hatchery Innovation Summit June 3rd 2014 Nusa Dua Bali, Indonesia 1

2 Content 1. Tomorrow Poultry Producer needs? 2. Why hatchery vaccination is the solution of tomorrow? 3. Evolution of practices in the 5 past years 4. Visions and Perspectives Content 1. Tomorrow Poultry Producer needs? 2. Why hatchery vaccination is the solution of tomorrow? 3. Evolution of practices in the 5 past years 4. Visions and Perspectives 2

3 1 Tomorrow s Poultry Producers needs? Ceva Survey 2013 Pressures, Plans and Problems of poultry producers 30 Large Broiler Producers Representing: 24% of the Global 2013 Broiler production Belonging to the Top10 in their country Belonging to the Top 100 at global level Geographical coverage: USA, Mexico, Brazil, Peru China, Thailand, Indonesia, Philippines, Russia, Turkey, Spain South Africa, Egypt, Saudi Arabia, Interviews and analysis carried out by Ceva Account managers and Customer contacts at national level. 3

4 3 Questions to Poultry Producers CEO / Production managers / Animal Health Managers 1. What PRESSURES do you presently face from an Economic, Social and Poultry market Context? 2. What PLANS do you have to cope with these Pressures? 3. What PROBLEMS do you face in implementing these Plans? Producer Survey Results Synthesis PRESSURES High Disease challenge High Feed cost Increasing Market Competition - Price pressure PLANS Increase Vaccination & Biosecurity Customized Vacc. Program per Zone or Season Investigate new production process & organization PROBLEMS Failure in disease control & production performances Lack of expertise & Internal knowledge Organization complexity & Internal alignment 4

5 Producer Survey Results Synthesis Disease challenge Economic constraint Prevention Optimization Process Innovation New tools & approaches Simplified Management Support & Staff Training Content 1. Tomorrow Poultry Producer needs? 2. Why hatchery vaccination is the solution of tomorrow? 3. Evolution of practices in the 5 past years 4. Visions and Perspectives 5

Vaccination Quality 16-Oct 23-Oct 30-Oct 06-Nov 13-Nov 20-Nov 21-Nov

- HUMAN and Vaccination FACTOR Process Management Control Hatchery A

farmers and field conditions : LIMITED work control 1 - HUMAN FACTOR

95,33% 96,40% 98,50% 98,00% 95,90% 98,33% 98,67% 97,25% 85% 80% 82,00%

6 Vaccination Quality 16-Oct 23-Oct 30-Oct 06-Nov 13-Nov 20-Nov 21-Nov 01-déc 11-Dic 12-Dic 18-Dic 30-Dic 15-Ene 29-Ene 10-Feb 3/6/2014 Labor 1 - HUMAN and Vaccination FACTOR Process Management Control Hatchery A dedicated team : MAXIMISED work control Broiler houses Thousands of farmers and field conditions : LIMITED work control 1 - HUMAN FACTOR Process Control Vaccinator A 100% 95% 90% 96,33% 99,00% 93,00% 98,67% 95,33% 96,40% 98,50% 98,00% 95,90% 98,33% 98,67% 97,25% 85% 80% 82,00% 84,00% Sub-Cutaneous Injection 75% 70% 65% 60% Dates of Audits Carlos.gonzalez@ceva.com 6

7 2 - EQUIPMENT Process control 2 - EQUIPMENT Process control Desvac IN LINE SPRAY 7

IB /ND (warm country ) 235 Orange TXVK18 3

8 2 - EQUIPMENT Process control Spray Vaccination Vaccination/Disease VMD (microns) Color Nozzle Booster 115 Inox TXSS2 IB Primer 153 Red TXVK6 ND primer 173 Grey TXVK8 Primer IB /ND (warm country ) 235 Orange TXVK18 3 VACCINE PREPARATION Process control Carlos.gonzalez@ceva.com 8

9 with a good day old chick HOMOGENEITY OF VACCINATION PERFORMANCE Immune complex IBD (SQ) 100 % Positive flocks Immune complex IBD (in ovo) 99.3 % Positive flocks Drinking water IBD 70 % Positive flocks Gumboro Elisa at slaughter SPAIN

10 Content 1. Tomorrow Poultry Producer needs? 2. Why hatchery vaccination is the solution of tomorrow? 3. Evolution of practices in the 5 past years 4. Visions and Perspectives Hatchery Injection Practices

New Technology vaccines at Hatchery Immune Complex &

Vac.: From 15 % to 51 % between 2008 and 2013 New

Broiler Prod. 10% 1% 3% 0% 85% IBD New Tech. Vacc.

Conventional New Technology Vaccines at Hatchery 2013 :

11 New Technology vaccines at Hatchery Immune Complex & Vector HVT Vaccines rhvt Global usage of New Technology Vac.: From 15 % to 51 % between 2008 and 2013 New Technology Vaccines at Hatchery 2008 : 15 % of Global Broiler Prod. 10% 1% 3% 0% 85% IBD New Tech. Vacc. ND New Tech. Vacc. LT New Tech. Vacc. AI New Tech. Vacc. Conventional New Technology Vaccines at Hatchery 2013 : 51 % of Global Broiler Prod. IBD New Tech. Vacc. % of Global Yearly Broiler Production 49% 35% ND New Tech. Vacc. LT New Tech. Vacc. AI New Tech. Vacc. 11% Conventional 1% 4% 11

Usage against IBD : From 12 % to 35% between 2008 and 2013 IBD New Technology Vaccines 2008 : 12 %

6% 4% Immune Complex IBD 90% Vector HVT IBD Conventional IBD IBD New Technology Vaccines 2013: 35%

IBD Usage against ND and LT: From 4% to 15% between 2008 and 2013 ND / LT - New Technology

Technology Vaccines 2013: 15 % of Global Broiler Prod 96% Vector FP LT Conventional ND and LT 11%

12 Usage against IBD : From 12 % to 35% between 2008 and 2013 IBD New Technology Vaccines 2008 : 12 % of Global Broiler Prod. 6% 4% Immune Complex IBD 90% Vector HVT IBD Conventional IBD IBD New Technology Vaccines 2013: 35% of Global Broiler Prod. % of Global Yearly Broiler Production 17% Immune Complex IBD 65% 18% Vector HVT IBD Conventional IBD Usage against ND and LT: From 4% to 15% between 2008 and 2013 ND / LT - New Technology Vaccines 2008 : 4 % of Global Broiler Prod 1% 2% 1% Vector HVT ND Vector HVT LT ND / LT - New Technology Vaccines 2013: 15 % of Global Broiler Prod 96% Vector FP LT Conventional ND and LT 11% 3% 1% Vector HVT ND Vector HVT LT % of Global Yearly Broiler Production 85% Vector FP LT Conventional ND and LT Vector HVT ND are leading the growth in ND control 12

6% Content 1. Tomorrow Poultry Producer needs? 2.

13 Main suppliers of New Technology vaccines New Technology Vaccines 2013 : % Yearly Broiler Production Per Company 27% Ceva Supplier A 49% Supplier B 17% Supplier C Conventional 2% 6% Content 1. Tomorrow Poultry Producer needs? 2. Why hatchery vaccination is the solution of tomorrow? 3. Evolution of practices in the 5 past years 4. Visions and Perspectives 13

Conclusion Hatchery vaccination brings more than a better Vaccination It changes the Poultry Production process: * Allowing a better process control * Simplifying management

14 Conclusion Hatchery vaccination brings more than a better Vaccination It changes the Poultry Production process: * Allowing a better process control * Simplifying management * Relieving organization and farmers from a number of field vaccinations, * Freeing time for essential activities related to rearing management. Thanks for your attention! 14

Gumboro symposium 19 th & 20th of January 2012 BUDAPEST. Dr Sylvain COMTE Head of Poultry Franchise Poultry Corporate Marketing Director FRANCE

Ceva s Vision in poultry vaccination Gumboro symposium 19 th & 20th of January 2012 BUDAPEST Dr Sylvain COMTE Head of Poultry Franchise Poultry Corporate Marketing Director FRANCE Yann Arthus Bertrand